Royal Bank of Canada
IMMX icon

Royal Bank of Canada’s Immix Biopharma IMMX Stock Holding History

Royal Bank of Canada’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Buy
1,356
+1,297
+2,198% +$12K ﹤0.01% 6510
2026
Q1 		$1K Sell
59
-936
-94% -$6.87K ﹤0.01% 6877
2025
Q4 		$5K Buy
+995
New +$4.09K ﹤0.01% 6712
2025
Q3 		– Sell
-11,168
Closed -$23K – 7300
2025
Q2 		$23K Buy
+11,168
New +$22.5K ﹤0.01% 6211
2025
Q1 		– Sell
-2,000
Closed -$4K – 7013
2024
Q4 		$4K Sell
2,000
-82,000
-98% -$150K ﹤0.01% 6581
2024
Q3 		$125K Buy
84,000
+83,867
+63,058% +$169K ﹤0.01% 5183
2024
Q2 		$0 Buy
133
+127
+2,117% +$292 ﹤0.01% 7271
2024
Q1 		$0 Sell
6
-62
-91% -$240 ﹤0.01% 7263
2023
Q4 		$0 Buy
+68
New +$308 ﹤0.01% 7325

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada's IMMX Position: Q2 2026 in Review

Royal Bank of Canada increased its Immix Biopharma (IMMX) stake by 2,198% in Q2 2026, buying an estimated $12K and bringing the position to 1,356 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #6510.

Royal Bank of Canada first reported a position in IMMX in Q4 2023 and has held it in 9 quarters since. The position peaked at $125K in Q3 2024. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Royal Bank of Canada held 1,356 shares of Immix Biopharma worth $14K as of Q2 2026.
  • Royal Bank of Canada bought 1,297 Immix Biopharma shares in Q2 2026, an estimated $12K.
  • Immix Biopharma made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6510 holding.
  • Royal Bank of Canada first reported a position in Immix Biopharma in Q4 2023 and has held it in 9 quarters since.
  • Royal Bank of Canada's Immix Biopharma position peaked at $125K in Q3 2024.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.